Role of P2X7 purinergic receptor in the regulation of hematopoietic stem cell and ...
| Grant number: | 11/09696-2 |
| Support type: | Regular Research Grants - Publications - Scientific article |
| Duration: | July 01, 2011 - December 31, 2011 |
| Field of knowledge: | Biological Sciences - Biochemistry |
| Principal Investigator: | Edgar Julian Paredes-Gamero |
| Grantee: | Edgar Julian Paredes-Gamero |
| Home Institution: | Instituto Nacional de Farmacologia (INFAR). Universidade Federal de São Paulo (UNIFESP). São Paulo , SP, Brazil |
Abstract
Extracellular nucleotides are emerging as key regulators of inflammation, cell proliferation and differentiation in a variety of tissues, including the hematopoietic system. In this study, the role of ATP was investigated during murine hematopoiesis. ATP was able to reduce the percentage of hematopoietic stem cells (HSCs), common myeloid progenitors and granulocyte-macrophage progenitors (GMPs), whereas differentiation into megakaryocyte-erythroid progenitors was not affected. Additionally, in vivo administration of ATP to mice reduced the number of GMPs but increased the number of Gr-1+Mac-1+ myeloid cells. ATP also induced an increased proliferation rate and reduced Notch expression in HSCs and impaired HSC-mediated bone marrow reconstitution in sub-lethally irradiated mice. Moreover, the effects elicited by ATP were inhibited by suramin, a P2 receptor antagonist, and BAPTA, an intracellular Ca2+ chelator. We further investigated whether the presence of cytokines might modulate the observed ATP-induced differentiation. Treatment of cells with cytokines (stem cell factor, interleukin-3 and granulocyte-monocyte colony stimulator factor) prior to ATP stimulation led to reduced ATP-dependent differentiation in long-term bone marrow cultures, thereby restoring the ability of HSCs to reconstitute hematopoiesis. Thus, our data suggest that ATP induces the differentiation of murine HSCs into the myeloid lineage and that this effect can be modulated by cytokines. (AU)